Stock listing

Lang & Schwarz:857216 Chugai Pharmaceutical Co., Ltd. Aktie

German listing (Lang & Schwarz) of Chugai Pharmaceutical Co., Ltd. · home listing Tokyo:4519

Follow Chugai Pharmaceutical Co., Ltd. into a list and get an email when it puts out news.

Chugai Pharmaceutical Co., Ltd. logo
Ticker
Lang & Schwarz:857216
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
Lang & Schwarz
Currency
EUR

What changed lately

Calls

Replays

  • Chugai Pharmaceutical (Tokyo:4519) Q2 2026 Earnings Call

    Fri, Jul 24, 2026 · 3:00 AM ET

    Watch Transcript

  • Chugai Pharmaceutical (Tokyo:4519) Q1 2026 Earnings Call

    Fri, Apr 24, 2026 · 5:00 AM ET

    Watch Transcript

  • Chugai Pharmaceutical (Tokyo:4519) Q4 2025 Earnings Call

    Thu, Jan 29, 2026 · 3:30 AM ET

    Watch Transcript

Latest news

Notice Regarding Discontinuation of Development of GYM329 (emugrobart) for Obesity, Return of License and Resumption of Development for SMA

Sep 28, 2026

Three Chugai Researchers Behind the Discovery of Hemlibra for Hemophilia A Receive Prestigious U.S. Lasker Award, One of the World’s Most Respected Scientific Honors

Sep 9, 2026

Chugai and GSK Sign Exclusive License Agreement for Anti-Dengue Virus Antibody AID351

Aug 18, 2026

Chugai Announces 2026 2nd Quarter Results

Jul 27, 2026

CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited) (for the six months ended June 30, 2026)

Jul 24, 2026

F. Hoffmann-La Roche Announces Half Year Results 2026

Jul 23, 2026

Chugai Files New Drug Application in Japan for Sparsentan for the Treatment of IgA Nephropathy

Jun 22, 2026

Chugai Receives The Imperial Invention Prize, the Highest Honor of the FY2026 National Commendation for Invention, Recycling Antibody Technology Recognized for its Contribution to Pharmaceutical Research

May 26, 2026

Chugai Pharmaceutical: Alecensa Receives the World-First Tumor-Agnostic Approval for ALK Fusion Gene-Positive Solid Tumors Across Adult and Pediatric Patients

May 18, 2026

Chugai Pharmaceutical Obtains Approval for FoundationOne CDx Cancer Genomic Profile as a Companion Diagnostic of Alecensa for ALK Fusion Gene-Positive Solid Tumors

May 18, 2026

All Chugai Pharmaceutical Co., Ltd. news

Decks

Chugai Pharmaceutical Co., Ltd. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
28 in the last 12 months · 34 in all · newest Sep 28, 2026 · oldest 2025
Calls
9 calls with a replay · 9 with a transcript · latest Jul 24, 2026
Decks
36 decks · latest Jul 24, 2026

Where Chugai Pharmaceutical Co., Ltd. is listed

ListingExchangeCountryCurrency
Tokyo:4519 中外製薬 · Home listingTokyoJapanJPY
OTC:CHGCYOTCUnited StatesUSD
OTC:CHGCFOTCUnited StatesUSD
gettex:CUPgettexGermanyEUR
Frankfurt:CUPFrankfurtGermanyEUR
Tradegate:CUPTradegateGermanyEUR
LS Exchange:857216LS ExchangeGermanyEUR
Lang & Schwarz:857216 · This pageLang & SchwarzGermanyEUR
BMV:4519NBMVMexicoMXN
Munich:CUPMunichGermanyEUR
Stuttgart:CUPStuttgartGermanyEUR
Hamburg:CUPHamburgGermanyEUR
Dusseldorf:CUPDusseldorfGermanyEUR
gettex:CUP0gettexGermanyEUR
Hanover:CUPHanoverGermanyEUR
BIVA:4519NBIVAMexicoMXN
Frankfurt:CUP0FrankfurtGermanyEUR
Munich:CUP0MunichGermanyEUR

Log in to ask 6ix AI your own questions about Chugai Pharmaceutical Co., Ltd.